30.01.2013 Views

Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_

Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_

Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Poster<br />

Topic: Trauma - Femur<br />

Abstract number: 26123<br />

PROSTHETIC USE AND MOBILITY WITH TRANSFEMORAL<br />

OSSEOINTEGRATED AMPUTATION PROSTHESIS, RESULTS FROM THE OPRA<br />

STUDY.<br />

Kerstin HAGBERG, Rickard BRåNEMARK<br />

Sahlgrenska University Hospital, Mölndal (SWEDEN)<br />

Treatment with osseointegrated transfemoral amputation prostheses (OI-prostheses)<br />

has been performed in Sweden since 1990. It comprises two surgeries and<br />

rehabilitation with a total treatment period of 12-18 months. In 1999 a prospective<br />

study named OPRA (Osseointegrated Prostheses for the Rehabilitation of Amputees)<br />

was started with the aim to report outcome at 2-years following the second surgery.<br />

Among the rehabilitation details prosthetic mobility and health related quality of life<br />

(HRQL) are assessed. The study includes 55 implants on 51 patients, with 4 patients<br />

treated bilaterally. Some preliminary results have previously been reported on<br />

subsets of the material. Those include statistically significant improved general and<br />

specific HRQL among the first 18 consecutive treated patients and decreased<br />

walking energy cost and increased walking habits among 20 patients with unilateral<br />

transfemoral amputation. In June <strong>2010</strong> all included patients will have been followed<br />

for 2 years and analyses of definitive results can be started. In January <strong>2010</strong> a total<br />

of 42 patients with 46 implants (50% male, 50% female, mean age 44 years (Sd<br />

12,9), cause of amputation; 62% trauma, 29% tumour, 9% other) had passed the 2year<br />

follow-up. Preoperatively 17% did not use any prosthesis and 60% reported<br />

daily prosthetic use. At 2-years follow-up 7% did not use prostheses at all and 87%<br />

reported to use the OI-prosthesis daily. Final outcome from the OPRA study will be<br />

reported during <strong>2010</strong>. Preliminary results indicate that treatment with transfemoral OIprosthesis<br />

improve prosthetic mobility and HRQL.<br />

529

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!